Skip to main content

Table 5 Functioning and familial burden for epilepsy

From: Evaluation of outcomes for psychosis and epilepsy treatment delivered by primary health care workers in Nepal: a cohort study

  Program (n = 71) Control (n = 20) ANCOVA Full cohort (n = 91)
Mean (SD) Mean (SD) Effect size
F, partial eta2
P-val* Mean (SD) Effect size
Z, r
P-val**
WHODAS 0.72, < 0.01 0.40    6.38, 0.67 < 0.0001
Baseline 35.6 (20.9) 25.8 (21.3)    33.5 (21.3)   
end point 10.2 (21.1) 12.8 (25.7)    10.8 (22.1)   
Δ score − 25.4 (28.4) − 13.1 (21.7)    − 22.7 (27.4)   
BAS < 0.01, < 0.01 0.98    8.09, 0.85 < 0.0001
Baseline 73.0 (7.9) 69.1 (9.0)    72.1 (8.3)   
end point 58.4 (6.6) 57.6 (6.4)    58.2 6.5   
Δ score − 14.6 (9.0) − 11.5 (8.6)    − 13.9 (8.9)   
  1. WHODAS World Health Organization Disability Assessment Schedule 2.0 Short Version, BAS burden assessment schedule
  2. * P-value taken from ANCOVA (analysis of covariance) for each scale comparing program vs. control scores at end point, adjusted for baseline score
  3. ** P-value from Wilcoxon Signed-Rank Test comparing baseline to end point scores (full cohort)